Setrusumab (Anti-SOST / Sclerostin)

Setrusumab (Anti-SOST / Sclerostin) is a fully humanized monoclonal antibody directed against sclerostin. Setrusumab effectively improves bone strength and has the potential to be used in the research of Osteogenesis Imperfecta (OI). MW :143.44 kD.
Supplier Selleck Chemicals
Product # A2690
Sku # A2690-1mg*25
Pricing 1mg*25, $5070.00
Feedback